Similar articles

• The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.

  Zeybel M, Ozder A, Sanlidag C, Yildiz S, Cavdar C, Ersoy R, Celik A, Camsari T. Zeybel M, et al. Adv Perit Dial. 2003;19:198-201. Adv Perit Dial. 2003. PMID: 14763062
• The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.

  Cavdar C, Zeybel M, Atay T, Sifil A, Sanlidag C, Gulay Z, Camsari T. Cavdar C, et al. Adv Perit Dial. 2004;20:62-6. Adv Perit Dial. 2004. PMID: 15384797 Clinical Trial.
• The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.

  Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. Thodis E, et al. Adv Perit Dial. 2000;16:257-61. Adv Perit Dial. 2000. PMID: 11045306 Clinical Trial.
• Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.

  Ritzau J, Hoffman RM, Tzamaloukas AH. Ritzau J, et al. Perit Dial Int. 2001 Sep-Oct;21(5):471-9. Perit Dial Int. 2001. PMID: 11757831 Review.
• Prevention of catheter related infections in patients on CAPD.

  Thodis E, Passadakis P, Vargemezis V, Oreopoulos DG. Thodis E, et al. Int J Artif Organs. 2001 Oct;24(10):671-82. Int J Artif Organs. 2001. PMID: 11817317 Review.